• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化患者症状出现的时间。

Timing of onset of symptoms in people with idiopathic pulmonary fibrosis.

作者信息

Hewson Thomas, McKeever Tricia M, Gibson Jack E, Navaratnam Vidya, Hubbard Richard B, Hutchinson John P

机构信息

Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham, UK.

出版信息

Thorax. 2017 Oct 11. doi: 10.1136/thoraxjnl-2017-210177.

DOI:10.1136/thoraxjnl-2017-210177
PMID:29021387
Abstract

Little is known about when symptoms of idiopathic pulmonary fibrosis first develop. We identified incident cases of idiopathic pulmonary fibrosis-clinical syndrome (IPF-CS) from a UK primary care database and assessed the frequency of consultations for common symptoms in the 5 years prior to diagnosis. 1671 cases were identified with 5 years of data prior to diagnosis. Breathlessness was the most common symptom, followed by cough. Cases were significantly more likely than controls to experience these symptoms (p<0.001), even 4-5 years before diagnosis (OR for breathlessness for this period 2.79, 95% CI 2.13 to 3.65). This suggests that some patients with IPF may be symptomatic for more than 5 years before diagnosis.

摘要

关于特发性肺纤维化的症状何时首次出现,目前所知甚少。我们从英国初级医疗数据库中识别出特发性肺纤维化临床综合征(IPF-CS)的新发病例,并评估了诊断前5年常见症状的就诊频率。共识别出1671例有诊断前5年数据的病例。呼吸困难是最常见的症状,其次是咳嗽。与对照组相比,这些病例出现这些症状的可能性显著更高(p<0.001),甚至在诊断前4至5年也是如此(此期间呼吸困难的比值比为2.79,95%置信区间为2.13至3.65)。这表明一些特发性肺纤维化患者在诊断前可能出现症状超过5年。

相似文献

1
Timing of onset of symptoms in people with idiopathic pulmonary fibrosis.特发性肺纤维化患者症状出现的时间。
Thorax. 2017 Oct 11. doi: 10.1136/thoraxjnl-2017-210177.
2
Historical database cohort study addressing the clinical patterns prior to idiopathic pulmonary fibrosis (IPF) diagnosis in UK primary care.针对英国初级保健中特发性肺纤维化 (IPF) 诊断前临床模式的历史数据库队列研究。
BMJ Open. 2020 May 30;10(5):e034428. doi: 10.1136/bmjopen-2019-034428.
3
Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis?结缔组织病的存在是否会影响肺纤维化患者的生存?
Respir Med. 2011 Dec;105(12):1925-30. doi: 10.1016/j.rmed.2011.08.015. Epub 2011 Sep 15.
4
5
Evaluation of a respiratory symptom diary for clinical studies of idiopathic pulmonary fibrosis.特发性肺纤维化临床研究中呼吸症状日记的评估。
Respir Med. 2018 Jan;134:130-138. doi: 10.1016/j.rmed.2017.11.011. Epub 2017 Nov 26.
6
Assessment and Management of Cough in Idiopathic Pulmonary Fibrosis: A Narrative Review.特发性肺纤维化中咳嗽的评估与管理:一项叙述性综述
Lung. 2023 Dec;201(6):531-544. doi: 10.1007/s00408-023-00653-3. Epub 2023 Nov 7.
7
Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study.特发性肺纤维化患者心血管疾病的风险因素:一项基于人群的研究。
Chest. 2015 Jan;147(1):150-156. doi: 10.1378/chest.14-0041.
8
Chronic breathlessness in patients with idiopathic pulmonary fibrosis: a major challenge for caregivers.特发性肺纤维化患者的慢性呼吸困难:护理人员面临的重大挑战。
Expert Rev Respir Med. 2016 Dec;10(12):1295-1303. doi: 10.1080/17476348.2016.1251843. Epub 2016 Nov 2.
9
Breathing pattern and breathlessness in idiopathic pulmonary fibrosis: An observational study.特发性肺纤维化患者的呼吸模式和呼吸困难:一项观察性研究。
Respirology. 2016 Feb;21(2):344-9. doi: 10.1111/resp.12686. Epub 2015 Nov 24.
10
PAciFy Cough-a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary Fibrosis Cough.帕西菲咳嗽:一项多中心、双盲、安慰剂对照、交叉试验,评估硫酸吗啡治疗肺纤维化咳嗽的疗效。
Trials. 2022 Mar 2;23(1):184. doi: 10.1186/s13063-022-06068-4.

引用本文的文献

1
Cough and dyspnea management in pulmonary fibrosis.肺纤维化中咳嗽与呼吸困难的管理
Curr Opin Support Palliat Care. 2025 Jun 1;19(2):103-110. doi: 10.1097/SPC.0000000000000753. Epub 2025 Mar 25.
2
Ratio of miRNA-29 to miRNA-199 expression coordinates mesenchymal stem cell repair of bleomycin-induced pulmonary injury.miRNA-29与miRNA-199表达的比值协调博来霉素诱导的肺损伤的间充质干细胞修复。
Mol Ther Nucleic Acids. 2025 Jan 21;36(1):102461. doi: 10.1016/j.omtn.2025.102461. eCollection 2025 Mar 11.
3
AI-powered evaluation of lung function for diagnosis of interstitial lung disease.
用于间质性肺疾病诊断的人工智能驱动的肺功能评估
Thorax. 2025 Jun 16;80(7):445-450. doi: 10.1136/thorax-2024-221537.
4
Comparing multi-texture fibrosis analysis versus binary opacity-based abnormality detection for quantitative assessment of idiopathic pulmonary fibrosis.比较多纹理纤维化分析与基于二元不透明度的异常检测用于特发性肺纤维化的定量评估。
Sci Rep. 2025 Jan 9;15(1):1479. doi: 10.1038/s41598-025-85135-7.
5
SULF1 expression is increased and promotes fibrosis through the TGF-β1/SMAD pathway in idiopathic pulmonary fibrosis.在特发性肺纤维化中,SULF1表达增加并通过TGF-β1/SMAD途径促进纤维化。
J Transl Med. 2024 Oct 1;22(1):885. doi: 10.1186/s12967-024-05698-3.
6
Quantitative CT analysis of idiopathic pulmonary fibrosis and correlation with lung function study.特发性肺纤维化的定量 CT 分析及其与肺功能研究的相关性。
BMC Pulm Med. 2024 Sep 5;24(1):437. doi: 10.1186/s12890-024-03254-9.
7
Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey.明确间质性肺病及时诊断和治疗的途径:美国德尔菲调查。
BMJ Open Respir Res. 2023 Nov 24;10(1):e001594. doi: 10.1136/bmjresp-2022-001594.
8
Speaking of the "Devil": Diagnostic Errors in Interstitial Lung Diseases.说到“魔鬼”:间质性肺疾病的诊断错误
J Pers Med. 2023 Nov 10;13(11):1589. doi: 10.3390/jpm13111589.
9
Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis.预防肺纤维化的临床试验方法
Ann Am Thorac Soc. 2023 Dec;20(12):1683-1693. doi: 10.1513/AnnalsATS.202303-188PS.
10
A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities.特发性肺纤维化和间质性肺异常的多基因风险评分。
Am J Respir Crit Care Med. 2023 Oct 1;208(7):791-801. doi: 10.1164/rccm.202212-2257OC.